Insider Trading Activity Opko Health, Inc. (NASDAQ:OPK) – CEO Bought 1,800 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Opko Health, Inc. (NASDAQ:OPK)

Phillip Md Et Al Frost , CEO of Opko Health, Inc. (NASDAQ:OPK) reportedly Bought 1,800 shares of the company’s stock at an average price of 6.04 for a total transaction amount of $10,872.00 SEC Form

Insider Trading History For Opko Health, Inc. (NASDAQ:OPK)

On 8/6/2012 Phillip Md Et Al Frost, Director, bought 115,000 with an average share price of $4.29 per share and the total transaction amounting to $493,350.00.View SEC Filing

On 8/7/2012 Phillip Md Et Al Frost, Director, bought 50,000 with an average share price of $4.27 per share and the total transaction amounting to $213,500.00.View SEC Filing

On 8/8/2012 Phillip Md Et Al Frost, Director, bought 47,500 with an average share price of $4.25 per share and the total transaction amounting to $201,875.00.View SEC Filing

On 8/9/2012 Phillip Md Et Al Frost, Director, bought 70,000 with an average share price of $4.24 per share and the total transaction amounting to $296,800.00.View SEC Filing

On 8/10/2012 Phillip Md Et Al Frost, Director, bought 100,000 with an average share price of $4.24 per share and the total transaction amounting to $424,000.00.View SEC Filing

On 8/13/2012 Phillip Md Et Al Frost, Director, bought 60,000 with an average share price of $4.22 per share and the total transaction amounting to $253,200.00.View SEC Filing

On 8/14/2012 Phillip Md Et Al Frost, Director, bought 45,000 with an average share price of $4.18 per share and the total transaction amounting to $188,100.00.View SEC Filing

Analyst Ratings For Opko Health, Inc. (NASDAQ:OPK)
These are 2 Hold Ratings, 5 Buy Ratings .
The current consensus rating for Opko Health, Inc. (NASDAQ:OPK) is Buy (Score: 2.71) with a consensus target price of $16.58 , a potential (174.10% upside)

Analyst Ratings History For Opko Health, Inc. (NASDAQ:OPK)

On 3/31/2016 Barrington Research Lower Price Target of rating Outperform with a price target of $17.00 to $16.00
On 6/16/2016 Deutsche Bank AG Lower Price Target of rating Hold with a price target of $11.00 to $10.00
On 8/9/2016 J P Morgan Chase & Co Set Price Target of rating Buy with a price target of $14.00
On 10/10/2016 Oppenheimer Holdings, Inc. Reiterated Rating Hold
On 1/3/2017 Laidlaw Reiterated Rating Buy with a price target of $22.00 to $19.00
On 3/5/2017 Standpoint Research Reiterated Rating Buy with a price target of $14.00
On 3/14/2017 Guggenheim Initiated Coverage of rating Buy with a price target of $25.00

Recent Trading Activity for Opko Health, Inc. (NASDAQ:OPK)
Shares of Opko Health, Inc. closed the previous trading session at 6.18 up +0.13 2.15% with 4,148,153 shares trading hands.